BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang F, Zhang L, Zhang C. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies. Tumour Biol 2016;37:163-75. [PMID: 26586396 DOI: 10.1007/s13277-015-4445-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Li M, Dong C, Sun B, Lei H, Wang Y, Gong Y, Sun L, Sun Z. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway. Life Sciences 2019;239:116946. [DOI: 10.1016/j.lfs.2019.116946] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
2 Lingling J, Xiangao J, Guiqing H, Jichan S, Feifei S, Haiyan Z. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge. Biomed Pharmacother 2019;112:108648. [PMID: 30780105 DOI: 10.1016/j.biopha.2019.108648] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
3 Dobre EG, Dinescu S, Costache M. Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer. Cancers (Basel) 2020;12:E2698. [PMID: 32967267 DOI: 10.3390/cancers12092698] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang H, Niu L, Jiang S, Zhai J, Wang P, Kong F, Jin X. Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer. Oncotarget 2016;7:86174-85. [PMID: 27863388 DOI: 10.18632/oncotarget.13363] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
5 Di Fiore R, Suleiman S, Drago-Ferrante R, Felix A, O'Toole SA, O'Leary JJ, Ward MP, Beirne J, Yordanov A, Vasileva-Slaveva M, Subbannayya Y, Pentimalli F, Giordano A, Calleja-Agius J. LncRNA MORT (ZNF667-AS1) in Cancer-Is There a Possible Role in Gynecological Malignancies? Int J Mol Sci 2021;22:7829. [PMID: 34360598 DOI: 10.3390/ijms22157829] [Reference Citation Analysis]
6 Song J, Xu Q, Zhang H, Yin X, Zhu C, Zhao K, Zhu J. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma. J Cell Biochem. 2018;119:4559-4569. [PMID: 29239017 DOI: 10.1002/jcb.26598] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 7.5] [Reference Citation Analysis]
7 Ji Z, Tang T, Chen M, Dong B, Sun W, Wu N, Chen H, Feng Q, Yang X, Jin R, Jiang L. C-Myc-activated long non-coding RNA LINC01050 promotes gastric cancer growth and metastasis by sponging miR-7161-3p to regulate SPZ1 expression. J Exp Clin Cancer Res 2021;40:351. [PMID: 34749766 DOI: 10.1186/s13046-021-02155-7] [Reference Citation Analysis]
8 Zhang YN, Qiang B, Fu LJ. Association of ANRIL polymorphisms with coronary artery disease: A systemic meta-analysis. Medicine (Baltimore) 2020;99:e22569. [PMID: 33080691 DOI: 10.1097/MD.0000000000022569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yao CY, Chen CH, Huang HH, Hou HA, Lin CC, Tseng MH, Kao CJ, Lu TP, Chou WC, Tien HF. A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes. Blood Adv 2017;1:1505-16. [PMID: 29296792 DOI: 10.1182/bloodadvances.2017008284] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
10 Huang X, Sun L, Wen S, Deng D, Wan F, He X, Tian L, Liang L, Wei C, Gao K, Fu Q, Li Y, Jiang J, Zhai R, He M. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma. Cancer Sci. 2020;111:3338-3349. [PMID: 32506598 DOI: 10.1111/cas.14516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Wu G, Weng W, Xia P, Yan S, Zhong C, Xie L, Xie Y, Fan G. Wnt signalling pathway in bladder cancer. Cell Signal 2021;79:109886. [PMID: 33340660 DOI: 10.1016/j.cellsig.2020.109886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu DY, Tang CJ, De W, Yang F. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer 2018;17:6. [PMID: 29329543 DOI: 10.1186/s12943-017-0756-y] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 20.8] [Reference Citation Analysis]
13 Chu M, Yuan W, Wu S, Wang Z, Mao L, Tian T, Lu Y, Zhu B, Yang Y, Wang B, Gao H, Jiang L, Zhuang X. Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls. Oncotarget 2016;7:78631-9. [PMID: 27732938 DOI: 10.18632/oncotarget.12530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
14 Li Y, Zhang D, Zhang Y, Xu X, Bi L, Zhang M, Yu B, Zhang Y. Association of lncRNA polymorphisms with triglyceride and total cholesterol levels among myocardial infarction patients in Chinese population. Gene 2020;724:143684. [PMID: 30898706 DOI: 10.1016/j.gene.2019.02.085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Hou Z, Xu X, Zhou L, Fu X, Tao S, Zhou J, Tan D, Liu S. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1. Tumour Biol 2017;39:1010428317718135. [PMID: 28720061 DOI: 10.1177/1010428317718135] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 7.4] [Reference Citation Analysis]
16 Huang X, Dai J, Lin K, Liu M, Ruan H, Zhang H, Liu W, He M, Zhao M. Regulation of IL-17 by lncRNA of IRF-2 in the pearl oyster. Fish & Shellfish Immunology 2018;81:108-12. [DOI: 10.1016/j.fsi.2018.07.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
17 Li Q, Li H, Zhao X, Wang B, Zhang L, Zhang C, Zhang F. DNA Methylation Mediated Downregulation of miR-449c Controls Osteosarcoma Cell Cycle Progression by Directly Targeting Oncogene c-Myc. Int J Biol Sci 2017;13:1038-50. [PMID: 28924385 DOI: 10.7150/ijbs.19476] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
18 Uboveja A, Satija YK, Siraj F, Saluja D. p73-regulated FER1L4 lncRNA sponges the oncogenic potential of miR-1273g-3p and aids in the suppression of colorectal cancer metastasis. iScience 2022;25:103811. [DOI: 10.1016/j.isci.2022.103811] [Reference Citation Analysis]
19 Nie F, Yu X, Huang M, Wang Y, Xie M, Ma H, Wang Z, De W, Sun M. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget 2017;8:38227-38. [PMID: 27246976 DOI: 10.18632/oncotarget.9611] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 22.8] [Reference Citation Analysis]
20 Wang G, Chen X, Liang Y, Wang W, Shen K. A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer. Transl Oncol 2017;10:988-97. [PMID: 29096247 DOI: 10.1016/j.tranon.2017.09.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
21 Li F, Li Q, Wu X. Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer. PLoS One 2018;13:e0192494. [PMID: 29420609 DOI: 10.1371/journal.pone.0192494] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
22 Li F, Huang C, Li Q, Wu X. Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer. Med Sci Monit 2018;24:37-49. [PMID: 29295970 DOI: 10.12659/msm.905410] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
23 Fang J, Qiao F, Tu J, Xu J, Ding F, Liu Y, Akuo BA, Hu J, Shao S. High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer. Oncotarget 2017;8:45918-27. [PMID: 28507281 DOI: 10.18632/oncotarget.17439] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
24 Wu H, Hu Y, Liu X, Song W, Gong P, Zhang K, Chen Z, Zhou M, Shen X, Qian Y, Fan H. LncRNA TRERNA1 Function as an Enhancer of SNAI1 Promotes Gastric Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition. Mol Ther Nucleic Acids 2017;8:291-9. [PMID: 28918030 DOI: 10.1016/j.omtn.2017.06.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
25 Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler M. Current Status of Long Non-Coding RNAs in Human Breast Cancer. Int J Mol Sci 2016;17:E1485. [PMID: 27608009 DOI: 10.3390/ijms17091485] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
26 Sun HT, Li JP, Qian WQ, Yin MF, Yin H, Huang GC. Quercetin suppresses inflammatory cytokine production in rheumatoid arthritis fibroblast-like synoviocytes. Exp Ther Med 2021;22:1260. [PMID: 34603528 DOI: 10.3892/etm.2021.10695] [Reference Citation Analysis]
27 Meyer SM, Williams CC, Akahori Y, Tanaka T, Aikawa H, Tong Y, Childs-Disney JL, Disney MD. Small molecule recognition of disease-relevant RNA structures. Chem Soc Rev 2020;49:7167-99. [PMID: 32975549 DOI: 10.1039/d0cs00560f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 17.0] [Reference Citation Analysis]
28 Li Z, Xu C, Ding B, Gao M, Wei X, Ji N. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101. J Neurooncol 2017;134:19-28. [PMID: 28551849 DOI: 10.1007/s11060-017-2498-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
29 Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ, Wang CY, Zhang HM, Zhang RX, Zhang JJ, Yao Z, Shen ZY. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. 2016;7:42431-42446. [PMID: 27285757 DOI: 10.18632/oncotarget.9883] [Cited by in Crossref: 126] [Cited by in F6Publishing: 164] [Article Influence: 31.5] [Reference Citation Analysis]
30 Wu J, Du M, Zhang Q, Zhang W, Fan Y, Yin L, Fei Q, Jiang X, Chen W, Zhu H, Yan P, He X, Bian X. Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145. Onco Targets Ther 2018;11:7483-92. [PMID: 30498361 DOI: 10.2147/OTT.S182290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
31 Zhang Y, Hu H. Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer. Tumour Biol 2017;39:1010428317699417. [PMID: 28631575 DOI: 10.1177/1010428317699417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
32 Yu W, Li D, Ding X, Sun Y, Liu Y, Cong J, Yang J, Sun J, Ning X, Wang H, Xu T. LINC00702 suppresses proliferation and invasion in non-small cell lung cancer through regulating miR-510/PTEN axis. Aging (Albany NY) 2019;11:1471-85. [PMID: 30840927 DOI: 10.18632/aging.101846] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
33 Hu J, Song C, Duan B, Zhang X, Li D, Zhu L, Gao H. LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma. Oncotarget. 2017;8:97835-97850. [PMID: 29228655 DOI: 10.18632/oncotarget.18279] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
34 Duan Y, Chen J, Yang Y, Qu Z, Lu Y, Sun D. LncRNA HOTAIR contributes Taxol-resistance of hepatocellular carcinoma cells via activating AKT phosphorylation by down-regulating miR-34a. Biosci Rep 2020;40:BSR20201627. [PMID: 32700738 DOI: 10.1042/BSR20201627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
35 Jonas K, Calin GA, Pichler M. RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer. Int J Mol Sci 2020;21:E2969. [PMID: 32340118 DOI: 10.3390/ijms21082969] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
36 Wang YG, Liu J, Shi M, Chen FX. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis. J Cell Physiol 2018;234:572-80. [PMID: 30216442 DOI: 10.1002/jcp.26779] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
37 Zhao B, Xu H, Ai X, Adalat Y, Tong Y, Zhang J, Yang S. Expression profiles of long noncoding RNAs in lung adenocarcinoma. Onco Targets Ther 2018;11:5383-90. [PMID: 30233202 DOI: 10.2147/OTT.S167633] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
38 Wang J, Zhang C, He W, Gou X. Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma. J Cell Biochem 2018. [PMID: 30278113 DOI: 10.1002/jcb.27557] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
39 Lin Y, Ge Y, Wang Y, Ma G, Wang X, Liu H, Wang M, Zhang Z, Chu H. The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population. Gene 2017;627:226-32. [PMID: 28627442 DOI: 10.1016/j.gene.2017.06.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
40 Berger H, Marques MS, Zietlow R, Meyer TF, Machado JC, Figueiredo C. Gastric cancer pathogenesis. Helicobacter. 2016;21 Suppl 1:34-38. [PMID: 27531537 DOI: 10.1111/hel.12338] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
41 Aram R, Dotan I, Hotz-Wagenblatt A, Canaani D. Identification of a novel metastasis inducing lncRNA which suppresses the KAI1/CD82 metastasis suppressor gene and is upregulated in triple-negative breast cancer. Oncotarget 2017;8:67538-52. [PMID: 28978052 DOI: 10.18632/oncotarget.18733] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
42 Guo N, Sun Q, Fu D, Zhang Y. Long non-coding RNA UCA1 promoted the growth of adrenocortical cancer cells via modulating the miR-298-CDK6 axis. Gene 2019;703:26-34. [DOI: 10.1016/j.gene.2019.03.066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
43 Shi B, Wang Y, Yin F. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells. Cancer Biol Ther. 2017;18:792-800. [PMID: 28857668 DOI: 10.1080/15384047.2017.1373214] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
44 Chen Y, Yan J. E2F1-induced PROX1-AS1 contributes to cell growth by regulating miR-424-5p/CPEB2 pathway in endometrial carcinoma. Mol Cell Toxicol 2022;18:91-100. [DOI: 10.1007/s13273-021-00176-z] [Reference Citation Analysis]
45 Zhou H, Ma Y, Zhong D, Yang L. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204. Biomedicine & Pharmacotherapy 2019;112:108633. [DOI: 10.1016/j.biopha.2019.108633] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
46 Yuan W, Li X, Liu L, Wei C, Sun D, Peng S, Jiang L. Comprehensive analysis of lncRNA-associated ceRNA network in colorectal cancer. Biochemical and Biophysical Research Communications 2019;508:374-9. [DOI: 10.1016/j.bbrc.2018.11.151] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
47 He W, Zhang D, Li D, Zhu D, Geng Y, Wang Q, He J, Wu J. Knockdown of Long Non-coding RNA LINC00200 Inhibits Gastric Cancer Progression by Regulating miR-143-3p/SERPINE1 Axis. Dig Dis Sci 2020. [PMID: 33141390 DOI: 10.1007/s10620-020-06691-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Liang Y, Wu Y, Chen X, Zhang S, Wang K, Guan X, Yang K, Li J, Bai Y. A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma. Biosci Rep 2017;37:BSR20171019. [PMID: 28939763 DOI: 10.1042/BSR20171019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
49 Li W, Fu Q, Man W, Guo H, Yang P. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway. European Journal of Pharmacology 2019;849:106-14. [DOI: 10.1016/j.ejphar.2019.01.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
50 Xia Y, Yan Z, Wan Y, Wei S, Bi Y, Zhao J, Liu J, Liao DJ, Huang H. Knockdown of long noncoding RNA GHET1 inhibits cell‑cycle progression and invasion of gastric cancer cells. Mol Med Rep 2018;18:3375-81. [PMID: 30066922 DOI: 10.3892/mmr.2018.9332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
51 Liu W, Zhang Y, Luo B. Long Non-coding RNAs in Gammaherpesvirus Infections: Their Roles in Tumorigenic Mechanisms. Front Microbiol 2020;11:604536. [PMID: 33519750 DOI: 10.3389/fmicb.2020.604536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Yang J, Wang X. Role of long non-coding RNAs in lymphoma: A systematic review and clinical perspectives. Crit Rev Oncol Hematol 2019;141:13-22. [PMID: 31202125 DOI: 10.1016/j.critrevonc.2019.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
53 Li L, Wang Y, Zhang X, Huang Q, Diao Y, Yin H, Liu H. Long non-coding RNA HOXD-AS1 in cancer. Clinica Chimica Acta 2018;487:197-201. [DOI: 10.1016/j.cca.2018.10.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
54 Xie CR, Wang F, Zhang S, Wang FQ, Zheng S, Li Z, Lv J, Qi HQ, Fang QL, Wang XM, Yin ZY. Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B. Mol Ther Nucleic Acids 2017;9:440-51. [PMID: 29246322 DOI: 10.1016/j.omtn.2017.10.018] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 9.8] [Reference Citation Analysis]
55 Wu Q, Xiang S, Ma J, Hui P, Wang T, Meng W, Shi M, Wang Y. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1. Mol Oncol 2018;12:799-813. [PMID: 29489064 DOI: 10.1002/1878-0261.12187] [Cited by in Crossref: 44] [Cited by in F6Publishing: 52] [Article Influence: 11.0] [Reference Citation Analysis]
56 Qi H, Yao L, Liu Q. NORAD affects the progression of diabetic nephropathy through targeting miR-520h to upregulate TLR4. Biochem Biophys Res Commun 2020;521:190-5. [PMID: 31630796 DOI: 10.1016/j.bbrc.2019.10.102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
57 Zheng W, Wu F, Fu K, Sun G, Sun G, Li X, Jiang W, Cao H, Wang H, Tang W. Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer. Onco Targets Ther 2021;14:3013-36. [PMID: 33986602 DOI: 10.2147/OTT.S301371] [Reference Citation Analysis]
58 Zhu L, Huang F, Wan T, Xu H, Zhao Q. Overexpression of long noncoding RNA LINC00882 is associated with poor prognosis in hepatocellular carcinoma. Onco Targets Ther 2018;11:5209-17. [PMID: 30271163 DOI: 10.2147/OTT.S170825] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wang J, Cao C, Zeng Q, Dong Z. [Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells in vitro via GSK-3β/β-catenin axis]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:679-84. [PMID: 31270046 DOI: 10.12122/j.issn.1673-4254.2019.06.08] [Reference Citation Analysis]
60 Zhao X, Zhang C, Wei X, Shi L, Dai S, Jia J, Wei S, Wang Y, Wang Y, Cheng J, Zhao L. CARLo-5 as an oncogenic gene in endometrial carcinoma. Environ Mol Mutagen 2020;61:256-65. [PMID: 31661565 DOI: 10.1002/em.22340] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Yu Z, Zeng J, Liu H, Wang T, Yu Z, Chen J. Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs. Oncol Lett 2019;17:3296-304. [PMID: 30867763 DOI: 10.3892/ol.2019.9962] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Hu G, Niu F, Humburg BA, Liao K, Bendi S, Callen S, Fox HS, Buch S. Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget. 2018;9:18648-18663. [PMID: 29719633 DOI: 10.18632/oncotarget.24307] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 20.0] [Reference Citation Analysis]
63 Dong R, Zhang B, Tan B, Lin N. Long non-coding RNAs as the regulators and targets of macrophage M2 polarization. Life Sci 2021;266:118895. [PMID: 33310042 DOI: 10.1016/j.lfs.2020.118895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Li X, Wu Y, Liu A, Tang X. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop. Tumor Biol 2016;37:14733-43. [DOI: 10.1007/s13277-016-5348-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 11.5] [Reference Citation Analysis]
65 Wang J, Luo Z, Yao T, Li W, Pu J. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway. J Cell Physiol 2019;234:6908-16. [PMID: 30317590 DOI: 10.1002/jcp.27449] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
66 Mi H, Wang X, Wang F, Li L, Zhu M, Wang N, Xiong Y, Gu Y. SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381. Onco Targets Ther 2020;13:657-66. [PMID: 32021307 DOI: 10.2147/OTT.S223321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
67 Wei C, Wang H, Xu F, Liu Z, Jiang R. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21. Biomed Pharmacother 2018;104:137-44. [PMID: 29772433 DOI: 10.1016/j.biopha.2018.05.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
68 Liu H, Zhang L, Ding X, Sui X. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway. Mol Med Rep 2021;23:24. [PMID: 33179755 DOI: 10.3892/mmr.2020.11662] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
69 Wu G, Xia P, Yan S, Chen D, Xie L, Fan G. Identification of unique long non-coding RNAs as putative biomarkers for chromophobe renal cell carcinoma. Per Med 2021;18:9-19. [PMID: 33052074 DOI: 10.2217/pme-2020-0020] [Reference Citation Analysis]
70 Zhuang X, Tong H, Ding Y, Wu L, Cai J, Si Y, Zhang H, Shen M. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Cell Death Dis 2019;10:620. [PMID: 31409775 DOI: 10.1038/s41419-019-1850-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
71 Wang XL, Shi M, Xiang T, Bu YZ. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway. J Cell Biochem 2019;120:275-82. [PMID: 30230592 DOI: 10.1002/jcb.27342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
72 Wang Y, Kuang H, Xue J, Liao L, Yin F, Zhou X. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Biomedicine & Pharmacotherapy 2017;93:1230-7. [DOI: 10.1016/j.biopha.2017.07.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
73 Yu MJ, Zhao N, Shen H, Wang H. Long Noncoding RNA MRPL39 Inhibits Gastric Cancer Proliferation and Progression by Directly Targeting miR-130. Genet Test Mol Biomarkers 2018;22:656-63. [PMID: 30452299 DOI: 10.1089/gtmb.2018.0151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
74 Tang RX, Chen WJ, He RQ, Zeng JH, Liang L, Li SK, Ma J, Luo DZ, Chen G. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma. Oncotarget 2017;8:50761-73. [PMID: 28881601 DOI: 10.18632/oncotarget.17098] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
75 Huang W, Shi Y, Han B, Wang Q, Zhang B, Qi C, Liu F. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis. Hum Cell 2020;33:416-26. [PMID: 32072565 DOI: 10.1007/s13577-020-00331-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
76 Poursheikhani A, Nokhandani N, Yousefi H, Rad DM, Sahebkar A. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis. CPB 2020;21:1422-32. [DOI: 10.2174/1389201021999200727163238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]